VTGNVistaGen Therapeutics, Inc.
0.2440USD-0.04%Mkt Cap: 10.83M $P/E: —3d ago
Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline inclu…